In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute

Cancer

Volumn 104, Issue 8, 2005, Pages 1733-1741

  Anderson, William F ^a   Devesa, Susan S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer in situ; Hormone receptor expression; Male breast carcinoma; Prognostic factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER SURVIVAL; CARCINOMA IN SITU; CELL SPECIFICITY; COMORBIDITY; DATA BASE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RARE DISEASE;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA IN SITU; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 26444564584     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21353     Document Type: Article

References (29)

1. Anderson WF, Chu KC, Devesa SS. Distinct incidence patterns among in-situ and invasive breast carcinomas, with possible etiologic implications. Breast Cancer Res Treat. 2004;88:149-159.
2. Hittmair AP, Lininger RA, Tavassoli FA. Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma: a preliminary report. Cancer. 1998;83:2139-2149.
3. Cutuli B, Dilhuydy JM, De Lafontan B, Berlie J, Lacroze M, Lesaunier F, et al. Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer. 1997;33:35-38.
4. SEER. Surveillance, Epidemiology, and End Results (SEER) Program. Public-Use Database (1973-2001), National Cancer Institute, DCCPS, Surveillence Research Program, Cancer Statistics Branch, based on the November 2003 submission. 2004.
5. Berg JW, Hutter RV. Breast cancer. Cancer. 1995;75(1 Suppl):257-269.
6. SEER. ICD-O-3 coding materials. Bethesda: National Cancer Institute, 2004.
7. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4:213-226.
8. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954;8:1-12.
9. Armitage P, Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer. 1957;11:161-169.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc A. 1972;135(A):185-198.
12. Cole FM, Qizilbash AH. Carcinoma in situ of the male breast. J Clin Pathol. 1979;32:1128-1134.
13. Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst. 2001;93:1811-1817.
14. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51-57.
15. Anderson WF, Devesa SS. Breast carcinoma in men [correspondence]. Cancer. 2004;103:432-433. [Reply, 2004;103:433-434].
16. Giordano SH, Buzdar AU, Hortobagyi GN. Author reply. Cancer. 2004;103:433-434.
17. Chu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA, et al. Recent trends in U. S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst. 1996;88:1571-1579.
18. Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stemhagen A, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control. 1993;4:143-151.
19. Camus MG, Joshi MG, Mackarem G, Lee AK, Rossi RL, Munson JL, et al. Ductal carcinoma in situ of the male breast. Cancer. 1994;74:1289-1293.
20. Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different from female breast cancer? Breast Cancer Res Treat. 2004;83:77-86.
21. Wellings SR. A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Pathol Res Pract. 1980;166:515-535.
22. Koc M, Oztas S, Erem MT, Ciftcioglu MA, Onuk MD. Invasive lobular carcinoma of the male breast: a case report. Jpn J Clin Oncol. 2001;31:444-446.
23. Rosen PP, Oberman HA. Tumors of the mammary gland, vol. Third series Fascicle 7. Washington, D. C.: Armed Forces Institue of Pathology, 1993.
24. Anderson WF, Chu KC, Chang S, Sherman ME. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:1128-1135.
25. Stalsberg H, Thomas DB. Age distribution of histologic types of breast carcinoma. Int J Cancer. 1993;54:1-7.
26. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature. 1983;303:767-770.
27. Brinton LA, Lacey J, Devesa SS. Epidemiology of breast cancer. In: Donegan WL, Spratt JS, editors. Cancer of the breast, 5th ed. Philadelphia: Saunders, 2002:111-132.
28. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15:17-35.
29. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83:498-509.